Entrada Therapeutics Inc (TRDA)
14.49
+0.30
(+2.11%)
USD |
NASDAQ |
May 15, 16:00
14.57
+0.08
(+0.55%)
After-Hours: 20:00
Entrada Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 87.29% |
Vertex Pharmaceuticals Inc | 87.27% |
Sarepta Therapeutics Inc | 87.77% |
PTC Therapeutics Inc | 92.98% |
GlycoMimetics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 9.83% |
Return on Assets | 4.82% |
Return on Invested Capital | 9.83% |
Profit Margin (Quarterly) | 39.74% |
Operating Margin (Quarterly) | 35.71% |
Return on Net Operating Assets | 23.42% |